Pricing Log in Create free account

Imunon, Inc. (IMNN) vs Orgenesis Inc. (ORGS)

Imunon, Inc. and Orgenesis Inc. are both Biotechnology companies. Imunon, Inc. and Orgenesis Inc. are of similar size ($6.0M and $5.7M). Orgenesis Inc. grew revenue faster over the last twelve months: 95.3% against 0.00%. Imunon, Inc. has the higher net margin (0.00% vs −4,653.6%) and the lower return on invested capital (−324.4% vs 0.00%). Across the 17 metrics below, Imunon, Inc. leads on 11 and Orgenesis Inc. on 6.

Valuation

Metric IMNN ORGS Biotechnology median
P/E n/m n/m 8.50
P/S 10.67 0.24 9.71
P/B 2.76 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.01 15.71 9.21
Earnings yield (375.49%) (19,183.33%) (33.15%)
Free cash flow yield (284.77%) (6,862.91%) (25.50%)

Profitability

Metric IMNN ORGS Biotechnology median
Gross margin 0.00% (86.28%) 65.16%
Operating margin 0.00% (3,842.32%) 0.00%
Net margin 0.00% (4,653.62%) 0.00%
Free cash flow margin 0.00% (1,675.27%) 0.00%
Return on equity (641.02%) 164.62% (56.36%)
Return on assets (123.93%) (605.73%) (48.04%)
Return on invested capital (324.37%) 0.00% 0.00%

Growth

Metric IMNN ORGS Biotechnology median
Revenue growth (TTM) 0.00% 95.28% 6.02%
EPS growth (last fiscal year) 67.66% 40.10% 30.26%
Revenue growth, 5-year CAGR 0.00% (23.30%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMNN ORGS Biotechnology median
Debt to equity 1.32 (0.44) 0.00
Current ratio 1.82 0.03 4.72
Net debt to EBITDA 0.63 (0.42) 0.96

Dividend

Metric IMNN ORGS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMNN ORGS Biotechnology median
Market cap 5.95m 5.68m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack